Thomas Jefferson University

Stephen Grubbs

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19023
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    U10CA045418     (GRUBBS, STEPHEN S.)Aug 5, 1987 - May 31, 2015
    NIH
    Delaware/Christiana Care Community Clinical Oncology Program
    Role: Principal Investigator
    UG1CA189819     (MASTERS, GREGORY A)Aug 1, 2014 - Jul 31, 2026
    NIH
    Delaware Christiana Care NCORP
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ng D, Belinske S, Hollinger D, Nagarajan S, Little H, Grubbs S, Bittner-Fagan H. Sustaining Improvements in Colorectal Cancer Across Delaware:: A Look at Racial Disparities a Decade Later. Dela J Public Health. 2024 Aug; 10(3):38-44. PMID: 39211400.
      Citations:    
    2. Bourbeau BR, Hagerty K, Dickson N, Polite B, Chasky M, Grubbs S. Practice Considerations for Participation in the Enhancing Oncology Model. JCO Oncol Pract. 2022 11; 18(11):737-741. PMID: 36252157.
      Citations:    
    3. Pennell NA, Dillmon M, Levit LA, Moushey EA, Alva AS, Blau S, Cannon TL, Dickson NR, Diehn M, Gonen M, Gonzalez MM, Hensold JO, Hinyard LJ, King T, Lindsey SC, Magnuson A, Marron J, McAneny BL, McDonnell TM, Mileham KF, Nasso SF, Nowakowski GS, Oettel KR, Patel MI, Patt DA, Perlmutter J, Pickard TA, Rodriguez G, Rosenberg AR, Russo B, Szczepanek C, Smith CB, Srivastava P, Teplinsky E, Thota R, Traina TA, Zon R, Bourbeau B, Bruinooge SS, Foster S, Grubbs S, Hagerty K, Hurley P, Kamin D, Phillips J, Schenkel C, Schilsky RL, Burris HA. American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. J Clin Oncol. 2021 01 10; 39(2):155-169. PMID: 33290128.
      Citations:    
    4. Blayney DW, Albdelhafeez N, Jazieh AR, Pinto CF, Udrea A, Roach A, Das D, Grubbs S, Hamm J, Jahanzeb M, Kamal AH, Kelly RJ, Martin SE, O'Mahony D, Birch W, Bowman R, Crist STS, Evers A, Gilmore T, Klein M, Siegel R. International Perspective on the Pursuit of Quality in Cancer Care: Global Application of QOPI and QOPI Certification. JCO Glob Oncol. 2020 05; 6:697-703. PMID: 32374622.
      Citations:    
    5. Ward JC, Bourbeau B, Chin AL, Page RD, Grubbs SS, Kamin DY, Green SR, Rappaport M. Updates to the ASCO Patient-Centered Oncology Payment Model. JCO Oncol Pract. 2020 05; 16(5):263-269. PMID: 32302272.
      Citations:    
    6. Bruinooge SS, Sherwood S, Grubbs S, Schilsky RL. Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies. J Oncol Pract. 2019 11; 15(11):575-583. PMID: 31386607.
      Citations:    
    7. Jones RT, Helm B, Parris D, Grubbs SS, Choy H, Kapetanovic K. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Made Simple for Medical and Radiation Oncologists: A Narrative Review. JAMA Oncol. 2019 May 01; 5(5):723-727. PMID: 30570664.
      Citations:    
    8. Grubbs SS. You Can Prevent Colon Cancer by Getting Screened. Dela J Public Health. 2018 Jul; 4(4):86-87. PMID: 34466994.
      Citations:    
    9. Polite BN, Seid JE, Levit LA, Kirkwood MK, Schenkel C, Bruinooge SS, Grubbs SS, Kamin DY, Schilsky RL. A New Look at the State of Cancer Care in America. J Oncol Pract. 2018 07; 14(7):397-399. PMID: 29906212.
      Citations:    
    10. Laslett NF, Park S, Masters GA, Biggs DD, Schneider CJ, Misleh JG, Suppiah K, Simpson PS, Grubbs S, Wozniak TF, Guarino M. Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancer. Cancer Med. 2018 Jul; 7(7):2969-2973. PMID: 29905018.
      Citations:    
    11. Shapiro CL, Moriarty JP, Dusetzina S, Himelstein AL, Foster JC, Grubbs SS, Novotny PJ, Borah BJ. Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance). J Clin Oncol. 2017 Dec 10; 35(35):3949-3955. PMID: 29023215.
      Citations:    
    12. McAneny B, Grubbs SS, Birch W, Sayam Zuckerman D. Making sense of advanced payment models. Am J Manag Care. 2017 Apr; 23(5 Spec No.):SP199-SP200. PMID: 28665679.
      Citations:    
    13. Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O'Connor T, Velasco MR, Weckstein D, O'Mara A, Loprinzi CL, Shapiro CL. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA. 2017 01 03; 317(1):48-58. PMID: 28030702.
      Citations:    
    14. Polite BN, Kamin DY, Grubbs SS. Reply to P.B. Bach. J Clin Oncol. 2016 12 20; 34(36):4448-4449. PMID: 27998228.
      Citations:    
    15. Dimond EP, Zon RT, Weiner BJ, St Germain D, Denicoff AM, Dempsey K, Carrigan AC, Teal RW, Good MJ, McCaskill-Stevens W, Grubbs SS, Dimond EP, Zon RT, Weiner BJ, St Germain D, Denicoff AM, Dempsey K, Carrigan AC, Teal RW, Good MJ, McCaskill-Stevens W, Grubbs SS. Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community. J Oncol Pract. 2016 Jan; 12(1):63-4, e23-35. PMID: 26627979.
      Citations:    
    16. Huynh TP, Barwe SP, Lee SJ, McSpadden R, Franco OE, Hayward SW, Damoiseaux R, Grubbs SS, Petrelli NJ, Rajasekaran AK. Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression. PLoS One. 2015; 10(4):e0122442. PMID: 25836370.
      Citations:    
    17. Grubbs SS, Polite BN, Carney J, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED. Eliminating racial disparities in colorectal cancer in the real world: it took a village. Del Med J. 2014 Oct; 86(10):301-5. PMID: 25647858.
      Citations:    
    18. Jagsi R, Spence R, Rathmell WK, Bradbury A, Peppercorn J, Grubbs S, Moy B. Ethical considerations for the clinical oncologist in an era of oncology drug shortages. Oncologist. 2014 Feb; 19(2):186-92. PMID: 24449096.
      Citations:    
    19. St Germain D, Denicoff AM, Dimond EP, Carrigan A, Enos RA, Gonzalez MM, Wilkinson K, Mathiason MA, Duggan B, Einolf S, McCaskill-Stevens W, Bryant DM, Thompson MA, Grubbs SS, Go RS. Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual. J Oncol Pract. 2014 Mar; 10(2):e73-80. PMID: 24424313.
      Citations:    
    20. Abernethy AP, Grubbs SS. Managing cumulative expectations in oncology: challenges and potential solutions. Am Soc Clin Oncol Educ Book. 2014; e140-4. PMID: 24857094.
      Citations:    
    21. Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, Dilts DM, Duff ME, Ford JG, Joffe S, Schapira L, Weinfurt KP, Michaels M, Raghavan D, Richmond ES, Zon R, Albrecht TL, Bookman MA, Dowlati A, Enos RA, Fouad MN, Good M, Hicks WJ, Loehrer PJ, Lyss AP, Wolff SN, Wujcik DM, Meropol NJ. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract. 2013 Nov; 9(6):267-76. PMID: 24130252.
      Citations:    
    22. Grubbs SS, Polite BN, Carney J, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013 Jun 01; 31(16):1928-30. PMID: 23589553.
      Citations:    
    23. Grubbs SS. The new national cancer institute national clinical trials network. Am Soc Clin Oncol Educ Book. 2012; 146-8. PMID: 24451724.
      Citations:    
    24. Paskett E, Herndon J, Donohue K, Naughton M, Grubbs S, Pavy M, Hensley M, Stark N, Kornblith A, Bittoni M. Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541. Cancer. 2009 Mar 01; 115(5):1109-20. PMID: 19170232.
      Citations:    
    25. Paskett ED, Herndon JE, Day JM, Stark NN, Winer EP, Grubbs SS, Pavy MD, Shapiro CL, List MA, Hensley ML, Naughton MA, Kornblith AB, Habin KR, Fleming GF, Bittoni MA. Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804. Psychooncology. 2008 Nov; 17(11):1108-20. PMID: 18314912.
      Citations:    
    26. Petrelli NJ, Grubbs S, Price K. Clinical trial investigator status: you need to earn it. J Clin Oncol. 2008 May 20; 26(15):2440-1. PMID: 18487564.
      Citations:    
    27. Werner-Wasik M, Axelrod RS, Friedland DP, Hauck W, Rose LJ, Chapman AE, Grubbs S, Deshields M, Curran WJ. Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy. Semin Radiat Oncol. 2002 Jan; 12(1 Suppl 1):34-9. PMID: 11917282.
      Citations:    
    28. Guarino MJ, Schneider CJ, Grubbs SS, Biggs DD, Himelstein AL, Hogaboom K, Tilak S. A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer. Oncologist. 2002; 7(6):509-15. PMID: 12490738.
      Citations:    
    29. Werner-Wasik M, Axelrod RS, Friedland DP, Hauck W, Rose LJ, Chapman AE, Grubbs S, DeShields M, Curran WJ. Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy. Clin Lung Cancer. 2001 May; 2(4):284-9; discussion 290. PMID: 14720361.
      Citations:    
    30. Grubbs SS, Tilton DC, Trayner E. Oncologic emergencies. Del Med J. 1990 Nov; 62(11):1339-47. PMID: 2276403.
      Citations:    
    31. Costanzi JJ, Cooper MR, Scarffe JH, Ozer H, Grubbs SS, Ferraresi RW, Pollard RB, Spiegel RJ. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma. J Clin Oncol. 1985 May; 3(5):654-9. PMID: 3998782.
      Citations:    
    Grubbs's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (149)
    Explore
    _
    Co-Authors (12)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _